Yüklüyor......
Temsirolimus in the treatment of relapsed or refractory mantle cell lymphoma
Mantle cell lymphoma (MCL) is a rare and aggressive subtype of lymphoma associated with a poor prognosis. Chemotherapy is the mainstay of frontline treatment for patients with this disease. Despite high response rates to combination chemotherapy regimens, the majority of patients relapse within a fe...
Kaydedildi:
| Asıl Yazarlar: | , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Dove Medical Press
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2939769/ https://ncbi.nlm.nih.gov/pubmed/20856791 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|